A decade-long project measuring access to healthy foods worldwide is wrapping up in August, after shedding new light on the ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in ... that have taken the world by storm. Nowadays, China ...

Analytic flow combining single-cell transcript data with WGS analysis. A liver disease related to metabolic abnormalities ...

Urban areas are particularly affected, with the prevalence reaching 26.8 per cent, compared to 18.3 per cent in rural regions. In major cities, the numbers are even more alarming: over 50 per cent of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Objective This report from the NORD-STAR (Nordic Rheumatic Diseases Strategy Trials and Registries) trial aimed to determine if obesity is associated with response to conventional and biological ...